Skip to content
Clinical resource

Anesthesia drug shortages

Drug shortages that affect anesthesia and perioperative care, drawn from the FDA and curated for South Carolina physician anesthesiologists. The Society tracks these so you can see at a glance what is in short supply.

Drawn from the FDA’s public Drug Shortages database; for awareness, not a basis for care decisions.

Latest changes

Recently updated

The most recent status changes the FDA posted for the drugs on this list.

The list

Shortages by drug

37 drugs tracked, 18 currently in shortage. As of August 31, 2026. Search for a drug, narrow the list by status, and open any drug to see its affected presentations.

37 drugs listed.

  • Atropine Sulfate Injection

    In shortage

    Injection · 8 companies

    Reasons: Discontinuation of the manufacture of the drug; Other; Requirements related to complying with good manufacturing practices

    Updated Aug 25, 2026

    21 presentations
    PresentationCompanyStatusUpdatedFDA note
    Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
    Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)"UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drugMore from the FDA
    Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)"UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drugMore from the FDA
    Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)AvailableAmphastar Pharmaceuticals, Inc.In shortageAug 18, 2026None
    Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)UnavailableAccord Healthcare Inc.In shortageAug 17, 2026Estimated recovery: September 2026
    Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)AvailableMedefil, Inc.In shortageAug 17, 2026None
    Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)UnavailableAccord Healthcare Inc.In shortageAug 17, 2026Discontinuation of the manufacture of the drug
    Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)AvailableAmerican Regent, Inc.In shortageAug 17, 2026None
    Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)UnavailableAccord Healthcare Inc.In shortageAug 17, 2026Estimated recovery: TBD
    Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)AvailableAmerican Regent, Inc.In shortageAug 17, 2026None
    Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)UnavailableAccord Healthcare Inc.In shortageAug 17, 2026Estimated recovery: TBD
    Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)AvailableAccord Healthcare Inc.In shortageAug 17, 2026None
    Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)UnavailableAccord Healthcare Inc.In shortageAug 17, 2026Discontinuation of the manufacture of the drug
    Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026None
    Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)"Hospira, Inc., a Pfizer CompanyTo be discontinuedNov 7, 2025Discontinuation of the manufacture of the drug
    Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)"Hospira, Inc., a Pfizer CompanyTo be discontinuedNov 7, 2025Discontinuation of the manufacture of the drug

    View Atropine Sulfate Injection on FDA.gov

  • Bupivacaine Hydrochloride Injection

    In shortage

    Injection · 8 companies

    Reasons: Delay in shipping of the drug; Demand increase for the drug; Discontinuation of the manufacture of the drug; Other

    Updated Aug 25, 2026

    59 presentations
    PresentationCompanyStatusUpdatedFDA note
    Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Historical NDC: 0409-1582-29
    Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
    Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: October 2026; Estimated Recovery: December 2026
    Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL (NDC 72266-263-10)AvailableONESOURCE SPECIALTY PTE LTDIn shortageAug 18, 2026Distributed by Fosun Pharma USA Inc.
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2)UnavailableHuons Co., LtdIn shortageJul 30, 2026Estimated recovery: TBD
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34)AvailableAspiro Pharma LimitedIn shortageJul 17, 2026None
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32)AvailableAspiro Pharma LimitedIn shortageJul 17, 2026None
    Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32)AvailableAspiro Pharma LimitedIn shortageJul 17, 2026None
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)AvailableAspiro Pharma LimitedIn shortageJul 17, 2026None
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34)AvailableAspiro Pharma LimitedIn shortageJul 17, 2026None
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34)AvailableAspiro Pharma LimitedIn shortageJul 17, 2026None
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)Kindos Pharmaceuticals Co. Ltd.To be discontinuedMay 5, 2026Discontinuation of the manufacture of the drug
    Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)Limited AvailabilityKindos Pharmaceuticals Co. Ltd.In shortageMay 5, 2026Meitheal Pharmaceuticals is distributor/labelerMore from the FDA
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)Kindos Pharmaceuticals Co. Ltd.To be discontinuedMay 5, 2026Discontinuation of the manufacture of the drug
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)Limited AvailabilityKindos Pharmaceuticals Co. Ltd.In shortageMay 5, 2026Meitheal Pharmaceuticals is distributor/labelerMore from the FDA
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)Kindos Pharmaceuticals Co. Ltd.To be discontinuedMay 5, 2026Discontinuation of the manufacture of the drug
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)Limited AvailabilityKindos Pharmaceuticals Co. Ltd.In shortageMay 5, 2026Meitheal Pharmaceuticals is distributor/labelerMore from the FDA
    Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)Kindos Pharmaceuticals Co. Ltd.To be discontinuedMay 5, 2026Discontinuation of the manufacture of the drug
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)Limited AvailabilityKindos Pharmaceuticals Co. Ltd.In shortageMay 5, 2026Meitheal Pharmaceuticals is distributor/labelerMore from the FDA
    Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)Kindos Pharmaceuticals Co. Ltd.To be discontinuedMay 5, 2026Discontinuation of the manufacture of the drug
    Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)Limited AvailabilityKindos Pharmaceuticals Co. Ltd.In shortageMay 5, 2026Meitheal Pharmaceuticals is distributor/labelerMore from the FDA

    View Bupivacaine Hydrochloride Injection on FDA.gov

  • Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

    In shortage

    Injection · 2 companies

    Reasons: Delay in shipping of the drug; Other

    Updated Aug 25, 2026

    20 presentations
    PresentationCompanyStatusUpdatedFDA note
    Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesaler for inventory
    Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesaler for inventory
    Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesaler for inventory
    Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 20267 month dating available on request. Check wholesalers for inventory.
    Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesaler for inventory
    Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None

    View Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection on FDA.gov

  • Dexmedetomidine Hydrochloride Injection

    In shortage

    Injection · 17 companies

    Reasons: Delay in shipping of the drug; Demand increase for the drug; Discontinuation of the manufacture of the drug; Other

    Updated Aug 27, 2026

    59 presentations
    PresentationCompanyStatusUpdatedFDA note
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)AvailableMeitheal Pharmaceuticals, Inc.In shortageAug 27, 2026None
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Expected recovery: TBD
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Expected recovery: TBD
    Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20)AvailablePfizer Inc.In shortageAug 24, 2026None
    Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01)AvailablePfizer Inc.In shortageAug 24, 2026None
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)AvailablePar Health, USA LLCIn shortageAug 18, 2026Please check wholesalers for inventory
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20)UnavailablePar Health, USA LLCIn shortageAug 18, 2026Estimated recovery: TBD; Please check wholesalers for inventory
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10)UnavailablePar Health, USA LLCIn shortageAug 18, 2026Estimated recovery: TBD; Please check wholesalers for inventory
    Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12)AvailableBaxter HealthcareIn shortageAug 17, 2026None
    Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24)UnavailableBaxter HealthcareIn shortageAug 17, 2026Estimated recovery: September 2026
    Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08)AvailableAzurity Pharmaceuticals, IncIn shortageAug 17, 2026Distributed by Wilshire Pharmaceuticals, Inc.
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24)AvailableHQ Specialty PharmaIn shortageAug 17, 2026Marketed by WG Critical Care
    Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)AvailableBaxter HealthcareIn shortageAug 17, 2026None
    Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10)AvailableAzurity Pharmaceuticals, IncIn shortageAug 17, 2026Distributed by Civica
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)AvailableHQ Specialty PharmaIn shortageAug 17, 2026Marketed by WG Critical Care
    Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08)AvailableAzurity Pharmaceuticals, IncIn shortageAug 17, 2026Distributed by Civica
    Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10)AvailableAzurity Pharmaceuticals, IncIn shortageAug 17, 2026Distributed by Wilshire Pharmaceuticals, Inc.
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)UnavailableAccord Healthcare Inc.In shortageAug 17, 2026Discontinuation of the manufacture of the drugMore from the FDA
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24)AvailableHQ Specialty PharmaIn shortageAug 17, 2026Marketed by WG Critical Care
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04)AvailableHQ Specialty PharmaIn shortageAug 17, 2026Marketed by WG Critical Care
    Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)AvailableBaxter HealthcareIn shortageAug 17, 2026None
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93)UnavailableAccord Healthcare Inc.In shortageAug 17, 2026Discontinuation of the manufacture of the drug
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe.
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95)AvailableJiangsu Hengrui Pharmaceuticals Co., Ltd.In shortageJul 30, 2026Marketed by Sandoz Inc.; Customer service: 800-525-8747
    Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)AvailableJiangsu Hengrui Pharmaceuticals Co., Ltd.In shortageJul 30, 2026Marketed by Sandoz Inc.; Customer service: 800-525-8747
    Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)AvailableJiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)In shortageJul 30, 2026Distributed by Avenacy; Contact information: 877-283-6229
    Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95)AvailableJiangsu Hengrui Pharmaceuticals Co., Ltd.In shortageJul 30, 2026Marketed by Sandoz Inc.; Customer service: 800-525-8747
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)AvailableGland Pharma LimitedIn shortageJul 22, 2026Distributed by DRL
    Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)AvailableGland Pharma LimitedIn shortageJul 22, 2026Marketed by Piramal Critical Care Inc.: 800-414-1901
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58)AvailableGland Pharma LimitedIn shortageJul 22, 2026Distributed by DRL
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8)AvailableAmneal PharmaceuticalsIn shortageJun 17, 2026Inventory available 4 to 5 month as per current demand. Next supply: week of 06/29/2026
    Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)AvailableAmneal PharmaceuticalsIn shortageJun 17, 2026None
    Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)AvailableAmneal PharmaceuticalsIn shortageJun 17, 2026None
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7)AvailableAmneal PharmaceuticalsIn shortageJun 17, 2026None
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06)Slayback PharmaTo be discontinuedJun 5, 2026Discontinuation of the manufacture of the drug
    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)Slayback PharmaTo be discontinuedJun 5, 2026Discontinuation of the manufacture of the drug
    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)Accord Healthcare Inc.To be discontinuedApr 21, 2026Discontinuation of the manufacture of the drug

    View Dexmedetomidine Hydrochloride Injection on FDA.gov

  • Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

    In shortage

    Injection · 2 companies

    Reasons: Demand increase for the drug; Other

    Updated Aug 25, 2026

    22 presentations
    PresentationCompanyStatusUpdatedFDA note
    Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release August 2026. Check wholesalers for inventory.
    Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: November 2026; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
    Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Limited Supply Available. Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
    Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
    Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
    Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
    Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    View Epinephrine Bitartrate, Lidocaine Hydrochloride Injection on FDA.gov

  • Etomidate Injection

    In shortage

    Injection · 6 companies

    Reasons: Demand increase for the drug; Other

    Updated Aug 24, 2026

    18 presentations
    PresentationCompanyStatusUpdatedFDA note
    Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay
    Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional product will be made available as it is released.
    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Novaplus label
    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Novaplus label
    Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Distributed by Civica
    Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional product will be made available as it is released.
    Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Distributed by Civica
    Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: TBD. Check wholesalers for inventory
    Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: TBD. Check wholesalers for inventory
    Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)AvailableGland Pharma LimitedIn shortageJul 22, 2026Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
    Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10)AvailableGland Pharma LimitedIn shortageJul 22, 2026Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
    Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10)AvailableCaplin Steriles, Ltd.In shortageJun 16, 2026Check wholesalers for inventory; Marketed by Fresenius Kabi
    Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)AvailableCaplin Steriles, Ltd.In shortageJun 16, 2026Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586
    Etomidate, Injection, 2mg/mL (NDC 65219-447-20)AvailableCaplin Steriles, Ltd.In shortageJun 16, 2026Check wholesalers for inventory; Marketed by Fresenius Kabi
    Etomidate, Injection, 2 mg/mL (NDC 72485-508-10)AvailableCaplin Steriles, Ltd.In shortageJun 16, 2026Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586

    View Etomidate Injection on FDA.gov

  • Fentanyl Citrate Injection

    In shortage

    Injection · 3 companies

    Reasons: Demand increase for the drug; Other

    Updated Aug 25, 2026

    19 presentations
    PresentationCompanyStatusUpdatedFDA note
    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
    Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Inventory available in vial presentations.
    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be available August 2026 timeframe. Product will be made available as it is released.
    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Inventory available in vial presentations.
    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be available September 2026 timeframe. Product will be made available as it is released.
    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Inventory available in vial presentations.

    View Fentanyl Citrate Injection on FDA.gov

  • Hydromorphone Hydrochloride Injection

    In shortage

    Injection · 4 companies

    Reasons: Demand increase for the drug; Other

    Updated Aug 25, 2026

    26 presentations
    PresentationCompanyStatusUpdatedFDA note
    Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesaler for inventory
    Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release not available at this time. Check wholesalers for inventory.
    Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release August 2026. Check wholesalers for inventory.
    Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release October 2026. Check wholesalers for inventory.
    Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release October 2026. Check wholesalers for inventory.
    Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
    Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
    Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
    Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
    Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)AvailableTeva Pharmaceuticals USA, Inc.In shortageAug 17, 2026None
    Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)AvailableTeva Pharmaceuticals USA, Inc.In shortageAug 17, 2026None
    Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)AvailableTeva Pharmaceuticals USA, Inc.In shortageAug 17, 2026None
    Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
    Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Product temporarily on backorder. Additional lots will be available in the August 2026 timeframe.

    View Hydromorphone Hydrochloride Injection on FDA.gov

  • Ketorolac Tromethamine Injection

    In shortage

    Injection · 7 companies

    Reasons: Delay in shipping of the drug; Demand increase for the drug; Other

    Updated Aug 25, 2026

    22 presentations
    PresentationCompanyStatusUpdatedFDA note
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Limited AvailabilitySagent PharmaceuticalsIn shortageAug 18, 2026Estimated recovery: late September 2026
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)AvailableSagent PharmaceuticalsIn shortageAug 18, 2026None
    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)UnavailableBaxter HealthcareIn shortageAug 17, 2026Estimated recovery: January 2027
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)UnavailableBaxter HealthcareIn shortageAug 17, 2026Estimated recovery: October 2026
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)AvailableGland Pharma LimitedIn shortageJul 22, 2026None
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)AvailableGland Pharma LimitedIn shortageJul 22, 2026Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)AvailableGland Pharma LimitedIn shortageJul 22, 2026Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
    Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)AvailableAlembic PharmaceuticalsIn shortageMay 15, 2026None
    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)AvailableAlembic PharmaceuticalsIn shortageMay 15, 2026None
    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)AvailableAlembic PharmaceuticalsIn shortageMay 15, 2026None

    View Ketorolac Tromethamine Injection on FDA.gov

  • Lidocaine Hydrochloride Injection

    In shortage

    Injection · 8 companies

    Reasons: Demand increase for the drug; Discontinuation of the manufacture of the drug; Other

    Updated Aug 25, 2026

    64 presentations
    PresentationCompanyStatusUpdatedFDA note
    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release October 2026. Check wholesalers for inventory.
    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
    Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drugMore from the FDA
    Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drugMore from the FDA
    Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)Limited AvailabilityAmphastar Pharmaceuticals, Inc.In shortageAug 18, 2026Available on allocation
    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
    Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
    Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: TBD. Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: TBD. Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: TBD. Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: end-August 2026. Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: mid-August 2026. Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30)AvailableAnthea PharmaIn shortageAug 4, 2026Distributed by Avenacy, LLC
    Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02)AvailableAnthea PharmaIn shortageAug 4, 2026Distributed by Avenacy, LLC
    Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)AvailableAnthea PharmaIn shortageAug 4, 2026Distributed by Avenacy, LLC
    Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20)AvailableAnthea PharmaIn shortageAug 4, 2026Distributed by Avenacy, LLC
    Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10)AvailableAnthea PharmaIn shortageAug 4, 2026Distributed by Avenacy, LLC
    Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50)AvailableAnthea PharmaIn shortageAug 4, 2026Distributed by Avenacy, LLC
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)UnavailableHuons Co., Ltd. (South Korea)In shortageJul 30, 2026Estimated recovery: TBD
    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)UnavailableSpectra Medical Devices, LLCIn shortageMay 15, 2026Estimated recovery: TBD
    Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4903-34)"Hospira, Inc., a Pfizer CompanyTo be discontinuedNov 7, 2025Discontinuation of the manufacture of the drug
    Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4904-34)"Hospira, Inc., a Pfizer CompanyTo be discontinuedNov 7, 2025Discontinuation of the manufacture of the drug

    View Lidocaine Hydrochloride Injection on FDA.gov

  • Meperidine Hydrochloride Injection

    In shortage

    Injection · 2 companies

    Reasons: Discontinuation of the manufacture of the drug; Other

    Updated Aug 24, 2026

    10 presentations
    PresentationCompanyStatusUpdatedFDA note
    Demerol, Injection, 75 mg/1 mL (NDC 0409-1179-30)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Demerol, Injection, 50 mg/1 mL (NDC 0409-1418-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Demerol, Injection, 100 mg/1 mL (NDC 0409-1180-69)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Demerol, Injection, 25 mg/1 mL (NDC 0409-1362-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
    Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    View Meperidine Hydrochloride Injection on FDA.gov

  • Midazolam Hydrochloride Injection

    In shortage

    Injection · 6 companies

    Reasons: Delay in shipping of the drug; Demand increase for the drug; Other

    Updated Aug 25, 2026

    26 presentations
    PresentationCompanyStatusUpdatedFDA note
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release October 2026. Check wholesalers for inventory.
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: October 2026; Estimated Recovery: December 2026
    Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)Limited AvailabilityHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2026
    Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: September 2026
    Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2026
    Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2026
    Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41)AvailableAvet Pharmaceuticals, Inc.In shortageAug 18, 2026None
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42)AvailableAvet Pharmaceuticals, Inc.In shortageAug 18, 2026None
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)Limited AvailabilityAvet Pharmaceuticals, Inc.In shortageAug 18, 2026Estimated recovery: 8/25/2026
    Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)AvailableWG Critical CareIn shortageAug 17, 2026Please check wholesalers and distributors for inventory.
    Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)AvailableWG Critical CareIn shortageAug 17, 2026Please check wholesalers and distributors for inventory.
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)UnavailableGland Pharma LimitedIn shortageJul 22, 2026Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals
    Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)UnavailableGland Pharma LimitedIn shortageJul 22, 2026Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals

    View Midazolam Hydrochloride Injection on FDA.gov

  • Morphine Sulfate Injection

    In shortage

    Injection · 5 companies

    Reasons: Demand increase for the drug; Discontinuation of the manufacture of the drug; Other

    Updated Aug 25, 2026

    24 presentations
    PresentationCompanyStatusUpdatedFDA note
    Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release October 2026. Check wholesalers for inventory.
    Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
    Morphine Sulfate, Injection, 8 mg/1 mL Syringes (NDC 0409-1892-01)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Discontinuation of the manufacture of the drug
    Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1)AvailableAmphastar Pharmaceuticals, Inc.In shortageAug 18, 2026None
    Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)AvailablePiramal Critical Care Inc.In shortageAug 4, 2026None
    Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)Limited AvailabilityPiramal Critical Care Inc.In shortageAug 4, 2026On allocation

    View Morphine Sulfate Injection on FDA.gov

  • Promethazine Hydrochloride Injection

    In shortage

    Injection · 2 companies

    Reasons: Demand increase for the drug; Other

    Updated Aug 13, 2026

    10 presentations
    PresentationCompanyStatusUpdatedFDA note
    Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026This presentation is temporarily on backorder. Expected in October 2026 timeframe
    Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
    Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)UnvailableXGen Pharmaceuticals DJB, Inc.In shortageJun 23, 2026Estimated recovery: TBD
    Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)AvailableXGen Pharmaceuticals DJB, Inc.In shortageJun 23, 2026None

    View Promethazine Hydrochloride Injection on FDA.gov

  • Remifentanil Hydrochloride Injection

    In shortage

    Injection · 3 companies

    Reasons: Delay in shipping of the drug; Demand increase for the drug

    Updated Aug 25, 2026

    9 presentations
    PresentationCompanyStatusUpdatedFDA note
    Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Ultiva, Injection, 5 mg (NDC 72078-036-05)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Ultiva, Injection, 2 mg (NDC 72078-035-02)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Estimated recovery: TBD
    Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be available. Product will be made available as it is released.

    View Remifentanil Hydrochloride Injection on FDA.gov

  • Rocuronium Bromide Injection

    In shortage

    Injection · 11 companies

    Reasons: Delay in shipping of the drug; Demand increase for the drug

    Updated Aug 27, 2026

    26 presentations
    PresentationCompanyStatusUpdatedFDA note
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)AvailableMeitheal Pharmaceuticals, Inc.In shortageAug 27, 2026None
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)AvailableMeitheal Pharmaceuticals, Inc.In shortageAug 27, 2026None
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release August 2026. Check wholesalers for inventory.
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Next release September 2026. Check wholesalers for inventory.
    Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)AvailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026None
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)AvailableMylan Institutional, a Viatris CompanyIn shortageAug 20, 2026None
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)AvailableSandoz Inc.In shortageAug 18, 2026None
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)AvailableSandoz Inc.In shortageAug 18, 2026None
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)AvailableSagent PharmaceuticalsIn shortageAug 18, 2026None
    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)AvailableBaxter HealthcareIn shortageAug 17, 2026None
    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)AvailableBaxter HealthcareIn shortageAug 17, 2026None
    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)AvailableXGen Pharmaceuticals DJB, Inc.In shortageAug 17, 2026Tamarang is the application holder and X-Gen is the distributor/labeler
    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)AvailableXGen Pharmaceuticals DJB, Inc.In shortageAug 17, 2026Tamarang is the application holder and X-Gen is the distributor/labeler
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be available. Product will be made available as it is released.
    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)AvailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Additional lots will be available. Product will be made available as it is released.
    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)Limited AvailabilityPiramal Critical Care Inc.In shortageAug 4, 2026On allocation
    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)Limited AvailabilityPiramal Critical Care Inc.In shortageAug 4, 2026On allocation

    View Rocuronium Bromide Injection on FDA.gov

  • Ropivacaine Hydrochloride Injection

    In shortage

    Injection · 5 companies

    Reasons: Delay in shipping of the drug; Demand increase for the drug; Other

    Updated Aug 25, 2026

    49 presentations
    PresentationCompanyStatusUpdatedFDA note
    Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesalers for inventory
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)UnavailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Estimated recovery: TBD
    Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026None
    Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)AvailableFresenius Kabi USA, LLCIn shortageAug 25, 2026Check wholesaler for inventory
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)AvailableInfoRLife SAIn shortageAug 18, 2026Marketed by Sagent Pharmaceuticals
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)UnavailableInfoRLife SAIn shortageAug 18, 2026Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)Limited AvailabilityInfoRLife SAIn shortageAug 18, 2026Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)AvailableInfoRLife SAIn shortageAug 18, 2026Marketed by Sagent Pharmaceuticals
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)AvailableInfoRLife SAIn shortageAug 18, 2026Marketed by Sagent Pharmaceuticals
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)AvailableInfoRLife SAIn shortageAug 18, 2026Marketed by Sagent Pharmaceuticals
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: TBD. Check wholesalers for inventory
    Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: end-August 2026. Check wholesalers for inventory
    Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10)UnavailableEugia US LLCIn shortageAug 6, 2026On backorder. Recovery: end-August 2026. Check wholesalers for inventory
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20)AvailableEugia US LLCIn shortageAug 6, 2026Check wholesalers for inventory
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25)AvailableSomerset Therapeutics, LLCIn shortageJul 20, 2026None
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10)AvailableCaplin Steriles, Ltd.In shortageJun 10, 2026Check wholesalers for inventory; Marketed by Baxter
    Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10)AvailableCaplin Steriles, Ltd.In shortageJun 10, 2026Check wholesalers for inventory; Marketed by Baxter
    Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10)Limited AvailabilityCaplin Steriles, Ltd.In shortageJun 10, 2026Limited supply; Check wholesalers for inventory; Marketed by Baxter
    Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10)Limited AvailabilityCaplin Steriles, Ltd.In shortageJun 10, 2026Check wholesalers for inventory; Marketed by Baxter

    View Ropivacaine Hydrochloride Injection on FDA.gov

  • Sufentanil Citrate Injection

    In shortage

    Injection · 2 companies

    Reason: Other

    Updated Aug 24, 2026

    4 presentations
    PresentationCompanyStatusUpdatedFDA note
    Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)UnavailableHospira, Inc., a Pfizer CompanyIn shortageAug 24, 2026Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
    Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Not currently manufactured
    Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Not currently manufactured
    Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)UnavailableHikma Pharmaceuticals USA, Inc.In shortageAug 13, 2026Not currently manufactured

    View Sufentanil Citrate Injection on FDA.gov

  • Acetaminophen; Oxycodone Hydrochloride Tablet

    To be discontinued

    Tablet · 1 company

    Updated Nov 3, 2025

    6 presentations
    PresentationCompanyStatusUpdatedFDA note
    Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 7.5 mg (NDC 60951-700-70)Endo Pharmaceuticals, Inc.To be discontinuedNov 3, 2025Discontinuation of the manufacture of the drug
    Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-85)Endo Pharmaceuticals, Inc.To be discontinuedNov 3, 2025Discontinuation of the manufacture of the drug
    Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 10 mg (NDC 60951-712-70)Endo Pharmaceuticals, Inc.To be discontinuedNov 3, 2025Discontinuation of the manufacture of the drug
    Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 2.5 mg (NDC 63481-627-70)Endo Pharmaceuticals, Inc.To be discontinuedNov 3, 2025Discontinuation of the manufacture of the drug
    Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 2.5 mg (NDC 60951-701-70)Endo Pharmaceuticals, Inc.To be discontinuedNov 3, 2025Discontinuation of the manufacture of the drug
    Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-70)Endo Pharmaceuticals, Inc.To be discontinuedNov 3, 2025Discontinuation of the manufacture of the drug

    View Acetaminophen; Oxycodone Hydrochloride Tablet on FDA.gov

  • Aspirin Suppository

    To be discontinued

    Suppository · 1 company

    Updated Jul 23, 2026

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Aspirin, Suppository, 300 mg (NDC 0574-7034-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug

    View Aspirin Suppository on FDA.gov

  • Belladonna and Opium Suppository

    To be discontinued

    Suppository · 1 company

    Updated Jul 23, 2026

    4 presentations
    PresentationCompanyStatusUpdatedFDA note
    Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug
    Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug
    Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug
    Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug

    View Belladonna and Opium Suppository on FDA.gov

  • Cisatracurium Besylate Injection

    To be discontinued

    Injection · 1 company

    Updated May 6, 2026

    2 presentations
    PresentationCompanyStatusUpdatedFDA note
    Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01)Hospira, Inc., a Pfizer CompanyTo be discontinuedMay 6, 2026Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug
    Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01)Hospira, Inc., a Pfizer CompanyTo be discontinuedMay 6, 2026Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug

    View Cisatracurium Besylate Injection on FDA.gov

  • Desflurane Liquid for Inhalation

    To be discontinued

    1 company

    Updated Jul 2, 2026

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Desflurane, Liquid for Inhalation, 240 mL/240 mL (NDC 0781-6172-86)Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)To be discontinuedJul 2, 2026Discontinuation of the manufacture of the drug; Distributed by Sandoz, Inc.

    View Desflurane Liquid for Inhalation on FDA.gov

  • Glycopyrrolate Injection

    To be discontinued

    Injection · 1 company

    Updated Jul 30, 2026

    4 presentations
    PresentationCompanyStatusUpdatedFDA note
    Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)Fresenius Kabi USA, LLCTo be discontinuedJul 30, 2026Discontinuation of the manufacture of the drug
    Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05)Fresenius Kabi USA, LLCTo be discontinuedJul 30, 2026Discontinuation of the manufacture of the drug
    Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02)Fresenius Kabi USA, LLCTo be discontinuedJul 30, 2026Discontinuation of the manufacture of the drug
    Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01)Fresenius Kabi USA, LLCTo be discontinuedJul 30, 2026Discontinuation of the manufacture of the drug

    View Glycopyrrolate Injection on FDA.gov

  • Homatropine Methylbromide and Hydrocodone Bitartrate Syrup

    To be discontinued

    Syrup · 1 company

    Updated Sep 11, 2025

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Hydromet, Syrup, 1.5 mg/5 mL; 5 mg/5 mL (NDC 0472-1030-16)Teva Pharmaceuticals USA, Inc.To be discontinuedSep 11, 2025None

    View Homatropine Methylbromide and Hydrocodone Bitartrate Syrup on FDA.gov

  • Hydrocortisone Acetate Suppository

    To be discontinued

    Suppository · 1 company

    Updated Jul 23, 2026

    2 presentations
    PresentationCompanyStatusUpdatedFDA note
    Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug
    Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug

    View Hydrocortisone Acetate Suppository on FDA.gov

  • Hydromorphone Hydrochloride Suppository

    To be discontinued

    Suppository · 1 company

    Updated Jul 23, 2026

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Hydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug

    View Hydromorphone Hydrochloride Suppository on FDA.gov

  • Ketamine Hydrochloride Injection

    To be discontinued

    Injection · 1 company

    Updated Nov 7, 2025

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)Pfizer Inc.To be discontinuedNov 7, 2025Discontinuation of the manufacture of the drug

    View Ketamine Hydrochloride Injection on FDA.gov

  • Ketorolac Tromethamine Tablet

    To be discontinued

    Tablet · 1 company

    Updated Apr 20, 2026

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)Mylan Pharmaceuticals Inc., a Viatris CompanyTo be discontinuedApr 20, 2026Discontinuation of the manufacture of the drug

    View Ketorolac Tromethamine Tablet on FDA.gov

  • Morphine Sulfate Suppository

    To be discontinued

    Suppository · 1 company

    Updated Jul 23, 2026

    4 presentations
    PresentationCompanyStatusUpdatedFDA note
    Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug
    Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug
    Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug
    Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12)Padagis US LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug

    View Morphine Sulfate Suppository on FDA.gov

  • Morphine Sulfate Tablet

    To be discontinued

    Tablet · 1 company

    Updated Dec 22, 2025

    2 presentations
    PresentationCompanyStatusUpdatedFDA note
    Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11)Upsher-Smith Laboratories, LLCTo be discontinuedDec 22, 2025Discontinuation of the manufacture of the drug
    Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11)Upsher-Smith Laboratories, LLCTo be discontinuedDec 22, 2025Discontinuation of the manufacture of the drug

    View Morphine Sulfate Tablet on FDA.gov

  • Neostigmine Methylsulfate Injection

    To be discontinued

    Injection · 1 company

    Updated Jan 12, 2026

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)Fresenius Kabi USA, LLCTo be discontinuedJan 12, 2026Discontinuation of the manufacture of the drug

    View Neostigmine Methylsulfate Injection on FDA.gov

  • Nitroglycerin Ointment

    To be discontinued

    Ointment · 1 company

    Updated Apr 14, 2026

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Rectiv, Ointment, 0.4% (NDC 58914-301-80)AbbVie Inc.To be discontinuedApr 14, 2026Discontinuation of the manufacture of the drug

    View Nitroglycerin Ointment on FDA.gov

  • Oxycodone Hydrochloride Oral Solution

    To be discontinued

    Oral Solution · 1 company

    Updated Sep 11, 2025

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Oxycodone Hydrochloride, Oral Solution, 5 mg/5 mL (NDC 0054-0390-41)Hikma Pharmaceuticals USA, Inc.To be discontinuedSep 11, 2025Hikma has permanently discontinued (NDC 0054-0390-41) for the 15 mL bottle configuration. Hikma will continue to distribute Oxycodone Hydrochloride Oral Solution 5 mg/5 mL in the 500 mL bottle (NDC 0054-0390-63).

    View Oxycodone Hydrochloride Oral Solution on FDA.gov

  • Phenobarbital Tablet

    To be discontinued

    Tablet · 1 company

    Updated Oct 31, 2025

    8 presentations
    PresentationCompanyStatusUpdatedFDA note
    Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-21)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug
    Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-32)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug
    Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-21)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug
    Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-21)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug
    Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-32)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug
    Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-21)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug
    Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-32)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug
    Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-32)Endo Pharmaceuticals, Inc.To be discontinuedOct 31, 2025Discontinuation of the manufacture of the drug

    View Phenobarbital Tablet on FDA.gov

  • Succinylcholine Chloride Injection

    To be discontinued

    Injection · 1 company

    Updated Jul 23, 2026

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10)Fresenius Kabi USA, LLCTo be discontinuedJul 23, 2026Discontinuation of the manufacture of the drug

    View Succinylcholine Chloride Injection on FDA.gov

  • Vecuronium Bromide Injection

    To be discontinued

    Injection · 1 company

    Updated Sep 8, 2025

    1 presentation
    PresentationCompanyStatusUpdatedFDA note
    Vecuronium Bromide, Injection, 20 mg (NDC 47335-932-44)Sun Pharmaceutical Industries LimitedTo be discontinuedSep 8, 2025The 10 mg presentation remains available.

    View Vecuronium Bromide Injection on FDA.gov

This list is drawn from the U.S. Food and Drug Administration’s public Drug Shortages database through the openFDA API, curated to the drugs used in anesthesia and perioperative care. It is national data gathered for South Carolina physician anesthesiologists, not a South-Carolina-specific supply report. The tracker was last refreshed on August 31, 2026.

The data may lag the FDA’s own site, and it is provided for awareness only. It is not a basis for medical care decisions, and you should not rely on it to make decisions about patient care. Confirm current status with the FDA Drug Shortages database and your own pharmacy. Data via openFDA.

The American Society of Health-System Pharmacists (ASHP) maintains the drug shortage list that most hospitals and pharmacies treat as the practitioner source of record. ASHP collects reports from manufacturers and practitioners directly, so its entries often appear sooner and carry management advice. Check the ASHP current shortages list alongside this tracker.